日本帕金森病患者处方模式的性别差异:使用保险索赔数据库进行了回顾性观察研究
Morinobu Seki1,2, Yayoi Kawata3, Ayako Hayashi3
1Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Frontiers in neurology
|July 21, 2025
概括
这项研究发现,在日本,更多的老年女性患有帕金森病 (PD). 虽然勒沃多巴是常见的,但在剂量和药物组合方面存在轻微的性别差异,这凸显了个性化PD管理的必要性.
科学领域:
- 神经学 神经学
- 老年病的医生 老年病的医生
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是老年人群中日益增长的一种神经退行性疾病.
- 现有的研究表明,在PD症状和治疗结果方面存在性别差异.
- 这就需要为帕金森病制定性别特定的管理策略.
研究的目的:
- 在日本对帕金森病患者进行性别分层分析.
- 根据性别调查人口统计特征,药物处方模式,以及基于性别的利沃多巴剂量.
- 确定帕金森病管理中的潜在的性别特异性趋势.
主要方法:
- 使用全国范围的日本医疗保健数据库进行的回顾性观察研究.
- 纳入标准:年龄≥30岁的患者在2016年6月至2021年5月期间被诊断患有PD.
- 对患者人口统计,药物处方和莱沃多巴剂量的描述性分析,按性别分层.
主要成果:
- 在39731名PD患者中,女性 (22,724) 超过男性 (17,007),特别是在75岁以上的年龄组.
- 利沃多巴是两性最常被处方的药物;平均最大利沃多巴剂量在男性 (520.0毫克) 和女性 (498.7毫克) 中的数量较高.
- 单胺氧化酶B抑制剂 (MAOBI) 的使用率在男性中为24.0%,在女性中为18.9%. 女性接受了更多样化的同时服用药物的范围.
结论:
- 分析证实,日本有大量患有PD的老年女性人口.
- 在莱沃多巴剂量和抗PD药物处方中观察到较小的基于性别的变化.
- 对PD的个性化治疗方法至关重要,考虑到潜在的性别特异性药物疗效和不良事件概况.
相关概念视频
Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
Parkinson's Disease: Overview
713
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
713
Bias in Epidemiological Studies
695
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
695
Factors Affecting Protein-Drug Binding: Patient-Related Factors
115
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
115
Neural Regulation
40.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.1K
Factors Influencing Drug Absorption: Disease States and Pharmacology
794
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
794


